Tuberculosis News and Research

Latest Tuberculosis News and Research

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

A recent study examines the potential effects of tobacco use on COVID-19.

21 Aug 2022

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Two days after arriving at a temporary migrant shelter at the border with the U.S. in June, Rosa Viridiana Ceron Alpizar's 9-year-old daughter and 1-year-old son fell ill. Most of the kids in the converted gym had stomach issues after being served a meal of sausage and beans, she recalled.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Next-generation sequencing system yields results comparable to traditional diagnostics

In the pursuit of accurate diagnoses for illnesses, doctors have traditionally used multiple methods — including culturing patient samples on a wide variety of media, reviewing countless medical records and analyzing clinical data using complex mathematical algorithms — to try to identify the bacterium, virus, fungus or other pathogen responsible for an infection.

10 Aug 2022

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments.

8 Aug 2022

BCG vaccine produces a "trained immunity response" which lasts more than a year

The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.

8 Aug 2022

Researchers develop new method for visualizing single cell protein secretion with stunning resolution

We have recently witnessed the stunning images of distant galaxies revealed by the James Webb telescope, which were previously visible only as blurry spots.

5 Aug 2022

What does the future look like for TB care?

In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.

5 Aug 2022

Johns Hopkins Medicine-led consortium awarded up to $200 million to address the global burden of tuberculosis

To address the global burden of tuberculosis (TB), one of humankind's oldest scourges, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by the U.S. Agency for International Development (USAID) Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB) project.

4 Aug 2022

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

The main challenges associated with existing lung cancer drugs are severe side effects and drug resistance. There is hence a constant need to explore new molecules for improving the survival rate and quality of life of lung cancer patients.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Researchers assessed the knowledge, attitudes, and practices (KAP) of healthcare workers (HCWs) towards monkeypox (MPX) in Italy.

29 Jul 2022

What is the optimal alcohol consumption level to minimize health loss?

Researchers performed a population-scale analysis of alcohol consumption by amount, age, gender, region, and year to estimate the theoretical minimum risk exposure level (TMREL) and the non-drinker equivalence (NDE).

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) recently launched a $577 million effort to develop antivirals against COVID-19 and other viruses with high pandemic potential.

15 Jul 2022

Alcohol consumption does not provide any health benefits, presents many risks for young people

Young people face higher health risks from alcohol consumption than older adults, according to a new analysis published in The Lancet.

15 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

University of Oxford begins recruiting for Phase I trial of new TB vaccine

The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines - with the first volunteers being challenged today (Wednesday).

12 Jul 2022

As California welcomes Ukrainian refugees, counties fall short on interpreters

After the Russian invasion, Katie Nelha and her husband couldn't safely return to their home in Mykolaiv, Ukraine, so they took their chances as refugees.

12 Jul 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

Modified TB vaccine could help treat non-muscle invasive bladder cancer

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Next-generation sequencing system yields results comparable to traditional diagnostics

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

BCG vaccine produces a "trained immunity response" which lasts more than a year

Researchers develop new method for visualizing single cell protein secretion with stunning resolution

What does the future look like for TB care?

Johns Hopkins Medicine-led consortium awarded up to $200 million to address the global burden of tuberculosis

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

What is the optimal alcohol consumption level to minimize health loss?

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Alcohol consumption does not provide any health benefits, presents many risks for young people

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

University of Oxford begins recruiting for Phase I trial of new TB vaccine

As California welcomes Ukrainian refugees, counties fall short on interpreters

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Tuberculosis News and Research

Latest Tuberculosis News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in